OrbiMed portfolio

OrbiMed (Venture capital) is known to hold 197 companies, 74 of them startups. 42 of them are hiring now, with 283 open roles. Its companies closed 19 venture rounds in 12 months, raising $1.4B. Most of them work in Drug Discovery, Oncology Therapeutics, Biologics & Biosimilars.

Source: Alion Venture capital Oct 27, 2026
Investments
197
74 of them startups
Hiring now
42
283 open roles
Rounds in 12 months
19
$1.4B raised
Exits
57

Companies OrbiMed has invested in

Aspen Neuroscience Cell & Gene Therapy portfolio pageSep 25
Belenos Bio Immunology & Inflammation Therapeutics portfolio pageSep 25
Binx Health Urgent & Emergency Care portfolio pageSep 25
biobeat Israel portfolio pageSep 25
Brenig Therapeutics, Inc. Neurology & CNS Therapeutics portfolio pageSep 25
Cellipont Cell & Gene Therapy portfolio pageSep 25
Chemomab Drug Discovery portfolio pageSep 25
Corvus Pharmaceuticals, Inc. Biologics & Biosimilars portfolio pageSep 25
Cubefabs Materials Science & Nanotechnology portfolio pageSep 25
Curevo Vaccine Infectious Disease Therapeutics portfolio pageSep 25
Cyrus Bio United States portfolio pageSep 25
EC Healthcare Precision Medicine portfolio pageSep 25
FUSmobile Surgical Instruments & Devices portfolio pageSep 25
Harvest IRO Clinical Trial Services (CRO) portfolio pageSep 25
Hocoma AG Physiotherapy & Rehabilitation portfolio pageSep 25
iECURE Cell & Gene Therapy portfolio pageSep 25
Insilico Drug Discovery AI · United States portfolio pageSep 25
iswaryafertility Fertility & IVF · India portfolio pageSep 25
Jizhun Yiliao United States portfolio pageSep 25
JRI Orthopaedics Ltd 3D Printers & Additive Manufacturing · China portfolio pageSep 25
Lifecell International Pvt Ltd Regenerative Medicine portfolio pageSep 25
Marksans Pharma Prescription Drugs portfolio pageSep 25
Mendra window Rare Disease Therapeutics portfolio pageSep 25
MinervaX Vaccines portfolio pageSep 25
MYFRIDO Books · India portfolio pageSep 25
Newmed China portfolio pageSep 25
Nucleus RadioPharma APIs & Drug Manufacturing portfolio pageSep 25
Odyssey Immunology & Inflammation Therapeutics · United States portfolio pageSep 25
Pathalys Pharma, Inc. Biologics & Biosimilars portfolio pageSep 25
ProVerum Medical Cardiovascular Devices portfolio pageSep 25
ReCodeTx Precision Medicine · United States portfolio pageSep 25
Sparrow Pharmaceuticals Prescription Drugs portfolio pageSep 25
SpectronRx Nuclear Energy portfolio pageSep 25
Star Sports Medicine Sports Medicine · China portfolio pageSep 25
Suraksha Diagnostic Limited Psychotherapy & Counseling portfolio pageSep 25
Topaz Therapeutics Oncology Therapeutics portfolio pageSep 25
Uquifa CRO & CDMO Services portfolio pageSep 25
Whale Imaging Medical Imaging Systems portfolio pageSep 25
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Health & Medical Electronics · Hong Kong portfolio pageSep 25
12

Focus

Markets
Drug Discovery11%
Oncology Therapeutics7%
Biologics & Biosimilars4%
Immunology & Inflammation Therapeutics4%
Rare Disease Therapeutics3%
Cell & Gene Therapy3%
Vaccines3%
Precision Medicine3%
Where its companies are
United States30%
China4%
India3%
Israel2%
Canada1%
United Kingdom1%
Belgium1%
Switzerland1%
Stage of its companies
Venture, series not stated71%
Series A12%
Series B10%
Series C and later7%

Questions about OrbiMed

How many companies has OrbiMed invested in?

OrbiMed is known to hold 197 companies: 74 startups, and 57 exits so far, read from its own portfolio page and the funding rounds that name it.

Is OrbiMed investing now?

OrbiMed has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does OrbiMed invest in?

The markets of the companies OrbiMed holds: Drug Discovery (11%), Oncology Therapeutics (7%), Biologics & Biosimilars (4%), Immunology & Inflammation Therapeutics (4%), Rare Disease Therapeutics (3%).

Which OrbiMed portfolio companies are hiring?

42 companies OrbiMed holds are hiring now, with 283 open roles listed on this page.

Who does OrbiMed invest alongside?

The investors that hold the most companies together with OrbiMed: RA Capital Management, Foresite Capital, SR One, Wellington Management, NEA.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 25; 3 rounds in the press that name it

OrbiMed portfolio: 197 known companies. Alion, Oct 27, 2026. https://alion.io/company/orbimed/portfolio

Licence: CC BY-SA 4.0JSON